Last $0.36 HKD
Change Today 0.00 / 0.00%
Volume 0.0
455 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 4:01 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

tianda pharmaceuticals ltd (455) Snapshot

Open
$0.35
Previous Close
$0.35
Day High
$0.36
Day Low
$0.34
52 Week High
03/11/14 - $0.50
52 Week Low
08/8/13 - $0.30
Market Cap
663.9M
Average Volume 10 Days
420.2K
EPS TTM
$0.01
Shares Outstanding
1.9B
EX-Date
--
P/E TM
28.6x
Dividend
$0.0024
Dividend Yield
1.15%
Current Stock Chart for TIANDA PHARMACEUTICALS LTD (455)

Related News

No related news articles were found.

tianda pharmaceuticals ltd (455) Related Businessweek News

No Related Businessweek News Found

tianda pharmaceuticals ltd (455) Details

Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products. Its principal product is Cerebroprotein Hydrolysate injection for treating craniocerebral trauma, and improving sequelae of cerebrovascular and deficiency of brain function, as well as for patients who lack protein or with neurasthenia. The company also provides ZhiKang granule for improving blood circulation and eliminating vascular plaques; Valsartan capsule, an antihypertensive drug; and Aceglutamide injection for traumatic brain injury coma, coma caused by nerve surgery, hepatic coma and paralysis, paraplegia, polio sequelae, nervous headache, low back pain, etc. It operates in the People’s Republic of China, Hong Kong, and Australia. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. Tianda Pharmaceuticals Limited is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

485 Employees
Last Reported Date: 06/27/14

tianda pharmaceuticals ltd (455) Top Compensated Officers

Chairman, Managing Director, Chairman of Nomi...
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

tianda pharmaceuticals ltd (455) Key Developments

Tianda Pharmaceuticals Limited Announces Audited Consolidated Earnings Results for the Year Ended March 31, 2014

Tianda Pharmaceuticals Limited announced audited consolidated earnings results for the year ended March 31, 2014. For the year, the company's revenue was HKD 247.17 million compared with HKD 180.2 million a year ago. Profit before tax was HKD 64.4 million compared with HKD 62.9 million a year ago. Profit for the year from continuing operations was HKD 48.95 million compared with HKD 50.8 million a year ago. Profit for the year was HKD 48.95 million compared with HKD 67.7 million a year ago. Profit for the year attributable to the owners of the company from continuing operations was HKD 22.0 million or 1.18 HKD cents per basic share compared with HKD 24.4 million or 1.30 HKD cents per basic share a year ago. Profit for the year attributable to the owners of the company was HKD 22.0 million or 1.18 HKD cents per basic share compared with HKD 37.7 million or 2.02 HKD cents per basic share a year ago.

Tianda Pharmaceuticals Limited Recommends Final Dividend for the Fiscal Year 2014

Tianda Pharmaceuticals Limited has recommended the payment of a final dividend of 0.24 cent per share for fiscal year 2014, subject to shareholders' approval at the forthcoming 2014 annual general meeting. For the year 2013 the company paid final dividend of 0.41 cent.

Tianda Pharmaceuticals Limited - Shareholder/Analyst Call

Tianda Pharmaceuticals Limited - Shareholder/Analyst Call

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
455:HK $0.36 HKD 0.00

455 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 455.
View Industry Companies
 

Industry Analysis

455

Industry Average

Valuation 455 Industry Range
Price/Earnings 29.7x
Price/Sales 2.6x
Price/Book 0.9x
Price/Cash Flow 29.7x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANDA PHARMACEUTICALS LTD, please visit www.tiandapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.